Česká republika - čeština - Ecolab

ecolab deutschland gmbh -

Evropská unie - čeština - EMA (European Medicines Agency)

pfizer ireland pharmaceuticals - avibactam sodium, ceftazidime pentahydrate - pneumonia, bacterial; soft tissue infections; pneumonia; urinary tract infections; gram-negative bacterial infections - antibakteriální látky pro systémové použití, - zavicefta is indicated in adults and paediatric patients aged 3 months and older for the treatment of the following infections:complicated intra-abdominal infection (ciai)complicated urinary tract infection (cuti), including pyelonephritishospital-acquired pneumonia (hap), including ventilator associated pneumonia (vap)treatment of patients with bacteraemia that occurs in association with, or is suspected to be associated with, any of the infections listed above. zavicefta is also indicated for the treatment of infections due to aerobic gram-negative organisms in adults and paediatric patients aged 3 months and older with limited treatment options. pozornost by měla být věnována oficiálním doporučením pro správné používání antibakteriálních látek.

Evropská unie - čeština - EMA (European Medicines Agency)

bayer healthcare ag - pradofloxacin - antibakteriální látky pro systémové použití - psi - psi: infekce kůže a měkkých tkání, . povrchové a hluboké pyodermie a hojení infekcí způsobených gram-pozitivní organismy, obvykle staphylococcus spp.. a streptococcus spp. a gram-negativních organismů, jako jsou escherichia coli, pseudomonas spp. a proteus spp.. infekce močových cest způsobené gram-negativních bakterií, jako jsou enterobacteriaceae, e. escherichia coli, enterobacter spp. , klebsiella spp. a proteus spp.. , pseudomonas spp. a gram-pozitivní organismy, obvykle staphylococcus spp.. , infekce dásní a parodontální tkáně vyvolaných anaerobními organismy, například porphyromonas spp. , prevotella spp. ; fusobacterium spp. , eikenellu spp. a capnophilic bakterií jako capnocytophaga spp. , , cats:, infections of the respiratory tract caused by gram-negative organisms such as pasteurella spp. , escherichia coli a pseudomonas spp. a gram-pozitivní mikroorganismy, jako jsou streptococcus spp. a staphylococcus spp..

Evropská unie - čeština - EMA (European Medicines Agency)

merck sharp & dohme b.v.  - imipenem monohydrát, cilastatin sodný, monohydrát relebactam - gram-negativní bakteriální infekce - carbapenems, antibacterials for systemic use, - recarbrio is indicated for:- treatment of hospital-acquired pneumonia (hap), including ventilator associated pneumonia (vap), in adults (see sections 4. 4 a 5. - treatment of bacteraemia that occurs in association with, or is suspected to be associated with hap or vap, in adults. - treatment of infections due to aerobic gram-negative organisms in adults with limited treatment options (see sections 4. 2, 4. 4, a 5. pozornost by měla být věnována oficiálním doporučením pro správné používání antibakteriálních látek.

Česká republika - čeština - SUKL (Státní ústav pro kontrolu léčiv)

lallemand sas, blagnac array - 807 lactobacillus helveticus; 812 lacticaseibacillus rhamnosus - tvrdá tobolka - 2x10^9cfu - organismy produkujÍcÍ kyselinu mlÉČnou

Evropská unie - čeština - EMA (European Medicines Agency)

roche registration ltd. - kyselina ibandronová - osteoporóza, postmenopauzální - léky na léčbu nemocí kostí - léčba osteoporózy u postmenopauzálních žen se zvýšeným rizikem zlomenin. snížení rizika vertebrálních zlomenin bylo prokázáno. Účinnost na stehenní-neck zlomeniny nebyla stanovena.

Evropská unie - čeština - EMA (European Medicines Agency)

novartis europharm limited - vildagliptin, metformin hydrochloridu - diabetes mellitus, typ 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - eucreas is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control.

Evropská unie - čeština - EMA (European Medicines Agency)

novartis europharm limited - vildagliptin, metformin hydrochloridu - diabetes mellitus, typ 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - icandra is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 a 5. 1 pro dostupné údaje o různých kombinacích).

Evropská unie - čeština - EMA (European Medicines Agency)

novartis europharm limited  - vildagliptin, metformin hydrochloridu - diabetes mellitus, typ 2 - léky užívané při diabetu - zomarist is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate.

Evropská unie - čeština - EMA (European Medicines Agency)

accord healthcare s.l.u. - metformin hydrochloride, vildagliptin - diabetes mellitus, typ 2 - léky užívané při diabetu - vildagliptin/metformin hydrochloride accord is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:- in patients who are inadequately controlled with metformin hydrochloride alone. - in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. - in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 a 5. 1 pro dostupné údaje o různých kombinacích).